Skip to main content

Containment Options for the Freeze-Drying of Biological Entities and Potent Materials

  • Protocol
  • First Online:
Lyophilization of Pharmaceuticals and Biologicals

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

Abstract

This chapter examines the characteristics and use of containment systems to perform various applications of freeze-drying. Specific consideration is given to containment system design, effects on mass and heat transfer, containment of microorganisms, and recommendations for the future application of containment options.

An assessment is made of previously characterized containment systems developed for freeze-drying which include a reusable aluminum box and the disposable Gore Lyoguard. Common design features of both were determined and a suitable, cost-effective, off the shelf alternative identified in the form of sterilization pouches. Further consideration is given to previous studies that have characterized and compared the effects on mass and heat transfer that barriers cause by increasing resistance to water vapor movement. In addition, the subsequent increases to heat transfer brought about by resistance to mass transfer are also further considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang W (2000) Lyophilisation and development of solid protein pharmaceuticals. Int J Pharm 203:1–60

    Article  CAS  Google Scholar 

  2. Trappler E (1995) Lyophilisation. In: Groves MJ, Murty R (eds) Aseptic pharmaceutical manufacturing II applications for the 1990s. Interpharm Press Incorporated, Buffalo Grove, IL

    Google Scholar 

  3. Snowman JW (1995) Lyophilisation under barrier technology. In: Groves MJ, Murty R (eds) Aseptic pharmaceutical manufacturing II applications for the 1990s. Interpharm Press Incorporated, Buffalo Grove, IL

    Google Scholar 

  4. Akers MJ (2010) Freeze-dry (lyophilisation) processing. In: Sterile drug products formulation, packaging, manufacturing and quality. Informa Healthcare, New York, NY

    Google Scholar 

  5. Suzuki O, Tanaka K, Watanabe N, Takeda M (2003) Design criteria and containment evaluation for pharmaceutical containment systems in aseptic dosage form manufacturing facilities. Pharm Technol 27:24–31

    Google Scholar 

  6. Taylor R, Boardman CFB, Wallis RG (1978) Sterile freeze-drying in an unclean environment. J Appl Chem Biotechnol 28:213–216

    Google Scholar 

  7. Gassler M, Rey L (2004) Development of a new concept for bulk freeze-drying: lyoguard freeze-dry packaging. In: Rey L, May JC (eds) Freeze-drying/lyophilization of pharmaceutical and biological products. 2nd edition, Informa Healthcare, New York, NY

    Google Scholar 

  8. Dunkelberg H, Rohmann S (2006) Test to determine sterile integrity of wrapped medical products at a probability of recontamination of 1:1,000,000. Infect Control Hosp Epidemiol 27(4):367–371

    Article  Google Scholar 

  9. Nolan PJ (2004) Sterile medical device package development. In: Standard handbook of biomedical engineering and design. McGraw-Hill, New York, NY

    Google Scholar 

  10. Dunkelberg H, Schmelz U (2009) Determination of the efficacy of sterile barrier systems against microbial challenges during transport and storage. Infect Control Hosp Epidemiol 30(2):179–183

    Article  Google Scholar 

  11. DuPont (2009) DuPont medical packaging guide technical reference guide

    Google Scholar 

  12. Pikal MJ (1985) Use of laboratory data in freeze-drying process design: heat and mass transfer coefficients and the computer simulation of freeze-drying. J Parenter Sci Technol 39:115–138

    CAS  PubMed  Google Scholar 

  13. Cherry CLA, Millward H, Cooper R, Landon J (2014) A novel approach to sterile pharmaceutical freeze-drying. Pharm Dev Technol 19(1):73–81

    Article  CAS  Google Scholar 

  14. Konstantinidis AK, Kuu W, Otten L, Nail SL, Sever RR (2011) Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate. J Pharm Sci 100(8):3453–3470

    Article  CAS  Google Scholar 

  15. Kuu WY, Hardwick LM, Akers MJ (2006) Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles. Int J Pharm 313:99–113

    Article  CAS  Google Scholar 

  16. Tang X, Nail SL, Pikal MJ (2006) Evaluation of manometric temperature measurement, a process analytical tool for freeze-drying: Part II measurement of dry layer resistance. AAPS PharmSciTech 7(4):E77

    Article  Google Scholar 

  17. Lu X, Pikal MJ (2004) Freeze-drying of mannitol-trehalose-sodium chloride based formulations: the impact of annealing on dry layer resistance to mass transfer and cake structure. Pharm Dev Technol 9(1):85–95

    Article  CAS  Google Scholar 

  18. Patel SM, Pikal MJ (2010) Freeze-drying in novel container systems: characterisation of heat and mass transfer in glass syringes. J Pharm Sci 99(7):3188–3204

    Article  CAS  Google Scholar 

  19. Adams GDJ (1991) The loss of substrate from a vial during freeze-drying using Escherichia coli as a trace organism. J Chem Technol Biotechnol 52:511–518

    Article  Google Scholar 

  20. Adams GDJ (1994) Freeze-drying of biohazardous products. In: Hambleton P, Melling J, Salusbury T (eds) Biosafety in industrial biotechnology. Chapman and Hall, London

    Google Scholar 

  21. Stein CD, Rogers H (1950) Recovery of viable microorganisms and viruses from vapors removed from frozen suspensions of biologic material during lyophilisation. Am J Vet Res 11:339–344

    CAS  PubMed  Google Scholar 

  22. Reitman M, Moss ML, Bruce Harstad J, Alg RL, Gross NH (1954) Potential infectious hazards of laboratory techniques. J Bacteriol 65(5):541–544

    Google Scholar 

  23. Busby D (1959) Contamination of apparatus during freeze-drying. J Hyg (London) 57:403–406

    Article  CAS  Google Scholar 

  24. Barbaree JM, Sanchez A (1982) Cross contamination during lyophilisation. Cryobiology 19:443–447

    Article  CAS  Google Scholar 

  25. Cammack KA, Adams GDJ (1985) Formulation and storage. In: Spier RE, Griffiths JB (eds) Animal cell biotechnology, vol 2. Academic Press Inc. Ltd., London

    Google Scholar 

  26. Adams GDJ (1996) Lyophilisation of vaccines. In: Robinson A, Farrar G, Wiblin C (eds) Methods in molecular medicine: vaccine protocols. Humana Press Inc., Totowa, NJ

    Google Scholar 

  27. Cherry CLA, Cooper R, Millward H, Landon J (2015) Proof of concept: containment systems that prevent freeze-dryer contamination when lyophilizing Escherichia coli (JM 109). Drying Technol 33(4):466–470

    Article  CAS  Google Scholar 

  28. Patel SM, Pikal MJ (2011) Emerging freeze-drying process development and scale-up issues. AAPS PharmSciTech 12(1):372

    Article  Google Scholar 

  29. Mayeresse Y, de Cupere V, Veillon R, Brendle J (2009) Considerations for transferring a bulk freeze-drying process from a glass container to a tray. Pharm Eng 29:36

    Google Scholar 

  30. Cherry CLA (2013) Development of novel containment systems for freeze-drying. Doctoral dissertation, Cardiff Metropolitan University

    Google Scholar 

  31. Nakamura T, Inatomi T, Sekiyama E, Ang LPK, Yokoi N, Kinoshita S (2006) Novel clinical application of sterilised, freeze-dried amniotic membrane to treat patients with pterygium. Acta Ophthalmol Scand 84:401–405

    Article  Google Scholar 

  32. Libera RD, Barreto de Melo B, Lima A, Haapalainen EF, Cristovam P, Gomes JAP (2008) Assessment of the use of cryopreserved freeze-dried amniotic membrane (AM) for the reconstruction of ocular surface in rabbit model. Arq Bras Oftalmol 71(5):669–673

    Article  Google Scholar 

  33. Jackson DW, Grood ES, Wilcox P, Butler DL, Simon TM, Holden JP (1988) The effects of processing techniques on the mechanical properties of bone-anterior cruciate ligament-bone allografts. Am J Sports Med 16(2):101–105

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chris Cherry .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Cherry, C. (2019). Containment Options for the Freeze-Drying of Biological Entities and Potent Materials. In: Ward, K., Matejtschuk, P. (eds) Lyophilization of Pharmaceuticals and Biologicals. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8928-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8928-7_6

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8927-0

  • Online ISBN: 978-1-4939-8928-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics